$EVER

EverQuote’s (NASDAQ:EVER) Q3 2026: strong sales, stock soars

EverQuote reported Q3 2026 revenue of $218.1M, beating estimates by 7.6% and growing 25.4% YoY. EPS met expectations at $0.49, while adjusted EBITDA exceeded forecasts by 19.6%. Q4 guidance was raised above consensus for both revenue ($218M) and EBITDA ($30.5M). Operating margin remained steady at 11%, and free cash flow margin improved to 17.7%.

Original reporting
Published Nov 2, 2026, 9:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
EverQuote’s (NASDAQ:EVER) Q3 2026: strong sales, stock soars — source image
Decision brief

The 30-second read

$EVERBullishHigh
01

Why it matters

Beats on revenue and adjusted EBITDA, plus above-consensus Q4 guidance midpoints, are the core catalysts for repricing the stock’s near-term growth and profitability expectations.

02

Market read

This is a company-specific earnings and guidance release with multiple above-consensus datapoints, making it actionable for positioning around near-term expectations.

03

What to watch

The excerpt lacks customer acquisition cost, churn, and cohort performance details; traders may discount guidance quality if those underlying drivers deteriorate.

Relevance 9/10Novelty 9/10Timing: after-hours/overnight following the Q3 2026 earnings release

Background

The article summarizes EverQuote’s Q3 2026 financial results and provides Q4 2026 guidance versus analyst consensus.

Company-level read

Ticker impact

$EVERBullishHigh confidence
Context

EverQuote reported Q3 2026 revenue of $218.1M vs $202.6M consensus and raised Q4 2026 guidance to $218M midpoint.

Expected impact

Likely upward pressure as the market prices in stronger Q4 revenue and EBITDA than consensus.

Evidence & confidence

The article provides multiple beat metrics (revenue, adjusted EBITDA) plus above-consensus Q4 guidance midpoints, which typically drives sustained post-earnings repricing.

Market effects

Strength in an online insurance lead-gen model can modestly support sentiment toward digital insurance marketing platforms and performance-based advertising peers.

Primarily US small-cap growth sentiment, with limited direct regional spillover beyond the broader earnings tape.

Low global relevance; impact is mostly confined to US-listed growth and insurtech-adjacent names.

Counterpoint

If the stock already priced in the earnings beat, upside may fade on any perceived sustainability risk in lead quality, CAC, or seasonality not discussed in the excerpt.

Key entities

  • EverQuote

    NASDAQ-listed online insurance marketplace reporting Q3 2026 results and issuing Q4 2026 guidance.

Related articles

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.

$EVERHigh

EverQuote (EVER) Q3 2026 Earnings Call Transcript

EverQuote (EVER) reported Q3 2026 earnings, exceeding guidance with 25% revenue growth to $218.1M and 41% adjusted EBITDA growth to $35.5M. The company highlighted strong performance in home insurance (70% YoY growth) and AI-driven initiatives, including new AI-native platforms and partnerships. The board authorized a $50M share repurchase program. Q4 2026 guidance projects 12% revenue growth.

$EVERMed

What EverQuote (EVER) Said on Its Q3 Earnings Call

EverQuote (EVER) reported Q3 operating cash flow of $40.5M, $229.1M in cash, and no debt. The board approved a $50M share buyback program. The company highlighted AI initiatives, including SmartCampaigns and the launch of Luva, an AI-native insurance platform. For Q4, EverQuote expects revenue of $213M-$223M, variable marketing dollars of $57M-$60M, and adjusted EBITDA of $29M-$32M, with a long-term goal of $1B in annual revenue.